Rising PSA levels during the course of prostate cancer progression may facilitate tumorigenesis by digesting IGFBP3 and releasing free IGF-1 into the prostate microenvironment (Cohen et al, 1992). Here, IGFBP3 is linked to prostate carcinoma.